Perceived Stress and Negative Thoughts With Biomarkers in People With Type 2 Diabetes Mellitus and Healthy Subjects

NCT ID: NCT04387045

Last Updated: 2020-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-02

Study Completion Date

2017-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effect of measured and induced negative feelings on glucose, tumor necrosis factor alpha, and cortisol levels in healthy participants and participants with type 2 diabetes mellitus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Depression and Diabetes are two pathologies that are frequently comorbid. Stress and negative thoughts are part of both. The biological correlates of psychological and emotional life are not yet fully clarified, so in this study we wonder about the association between tumor necrosis factor alpha, cortisol, and peripheral glucose levels with depression stress, measured negative thoughts, and induced guilt.This is a randomized intervention study. At baseline, participants complete the Beck Depression Inventory, the Automatic Negative Thoughts Scale (ATQ-N), and the Perceived Stress Scale (PSS-14). The intervention consists of a written task about situations that involved feelings of guilt or neutral situations. Saliva and dextrostix samples are taken before the 20-minute written task, at the end, dextrostix and saliva samples are performed again, finally a blood sample is taken.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guilty feelings

Write for 20 minutes about a situation that in the participant's past life has caused feelings of guilt.

Group Type EXPERIMENTAL

Guilty feelings

Intervention Type BEHAVIORAL

Participants write for 20 minutes about situations that have caused them feelings of guilt throughout their lives.

Neutral feelings

Write for 20 minutes about a situation that in the participant's past life has caused neutral feelings.

Group Type PLACEBO_COMPARATOR

Guilty feelings

Intervention Type BEHAVIORAL

Participants write for 20 minutes about situations that have caused them feelings of guilt throughout their lives.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guilty feelings

Participants write for 20 minutes about situations that have caused them feelings of guilt throughout their lives.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written, informed consent.
* 30 to 65 years of age.
* Current diagnosis of Diabetes mellitus type 2 without diabetic foot.
* Healthy volunteers.
* Ability to read and write.

Exclusion Criteria

* Other current or past chronic disease diagnoses.
* Current use of antidepressants or other psychiatric medications.
* Steroid medication.
* Consumption of tobacco or alcohol in the last 24 hours.
* Previous diagnosis of autoimmune diseases
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Francisco Carlos López Marquez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francisco Carlos López Marquez

Director of Biomedical research center, Faculty of Medicine, Torreón unit.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francisco C. López Marquez, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad Autonoma de Coahuila, Centro de investigación Biomédica

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Facultad de medicina De la UADEC Unidad Torreón

Torreón, Coahuila, Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C.B/02-01-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Managing Diabetes Mindfully Study
NCT01796834 COMPLETED NA
Decreasing Stress in Diabetes
NCT04016415 COMPLETED NA